The funding will support regulatory certification and the commercial launch of rapid tests for Lyme disease and sexually transmitted infections.
Clinical labs help drive early HIV detection and support efforts to prevent its spread.
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
WHO invited manufacturers of mpox IVDs to submit expressions of interest for Emergency Use Listing in response to rising cases in Africa.
Read More
QuidelOrtho received FDA 510(k) clearance for its VITROS syphilis assay, expanding its test portfolio to address the syphilis epidemic.
Read More
Eurofins has launched the Mplex Mpox, Orthopox real-time PCR assay for the qualitative detection and differentiation of the mpox virus.
Read More
Virax Biolabs secured a distribution agreement to commercialize Mpox detection kits across Europe and for Gulf Cooperation Council nations.
Read More
Seegene Inc. has developed new PCR test assays to detect mpox aimed at aiding in global research and diagnostics efforts.
Read More
The FDA granted marketing authorization to NOWDiagnostics for its syphilis test, the first OTC at-home test to detect syphilis antibodies.
Read More
A study highlights significant gaps in adherence to guideline-based testing and treatment for chlamydia and gonorrhea for pregnant women.
Read More
A study by FAIR Health reveals a 4.8 percent increase in STD diagnoses among commercially insured patients from 2020 to 2023.
Read More
Researchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.
Read More
Syphilis cases are rising globally, yet many Americans remain unaware of its symptoms and treatment options.
Read More
There has been significant rise in sexually transmitted infections (STIs), underscoring the need for improved STI testing and diagnostics.
Read More
Syphilis cases in Tennessee have surged among women, due to insufficient prenatal testing and treatment, compounded by a penicillin shortage.
Read More
Testmate Health secured $6 million in seed funding to develop an OTC self-test for STIs, initially targeting chlamydia and gonorrhea.
Read More
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read More
To increase the amount of syphilis testing, labs need to remove moral judgement and acknowledge the STI as just another infection.
Read More